TAIJI GROUP(SH:600129) Zheng Quan Zhi Xing·2025-08-21 13:13Core Viewpoint - The report evaluates the ongoing risks associated with the financial transactions between Chongqing Taiji Industrial (Group) Co., Ltd. and China National Pharmaceutical Group Financial Co., Ltd., confirming the latter's compliance with regulatory requirements and sound risk management practices [1][9]. Group 1: Basic Information of China National Pharmaceutical Group Financial Co., Ltd. - Established in February 2012, the company is a non-bank financial institution approved by the former China Banking Regulatory Commission [1]. - The registered capital is RMB 2.2 billion, with 100% ownership by its shareholders [1]. - The business scope includes accepting deposits, providing loans, bill discounting, and various financial advisory services [1]. Group 2: Internal Control and Risk Management - The company has established a comprehensive internal control system, including a governance structure with a board of directors and various committees [2][3]. - A risk management department and an internal audit department are in place to oversee business activities and ensure compliance with established procedures [2][3]. - The internal control system includes specific guidelines for settlement and credit operations, ensuring effective risk management [3][4]. Group 3: Operational and Financial Performance - As of June 30, 2025, the total assets of the company amounted to RMB 41.867 billion, with a loan balance of RMB 17.319 billion and an operating income of RMB 372 million [6][7]. - The company has maintained stable operations and steady growth across its various business lines since its inception [6][7]. Group 4: Regulatory Compliance - As of June 30, 2025, all regulatory indicators of the company met the required standards, including a loan-to-deposit ratio of 43.41% [8]. - The company has not encountered any significant deficiencies in its risk control systems related to financial reporting and management [7][9]. Group 5: Risk Assessment Conclusion - The company possesses valid financial licenses and has adhered to the regulations set forth in the Enterprise Group Financial Company Management Measures [9]. - The risk management practices of the company are deemed effective, with no major flaws identified in its operations [9].